Results 221 to 230 of about 36,503 (286)

No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma [PDF]

open access: gold, 2010
Annette Juul Vangsted   +9 more
openalex   +1 more source

Evaluation of the activity of CYP2C19 in Gujrati and Marwadi subjects living in Mumbai (Bombay)

open access: hybrid, 2006
Tanmay S. Panchabhai   +5 more
openalex   +1 more source

Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group [PDF]

open access: yes, 2012
Boineau, Robin   +10 more
core   +2 more sources

Genomic and Precision Medicine Approaches in Atherosclerotic Cardiovascular Disease: From Risk Prediction to Therapy-A Review. [PDF]

open access: yesBiomedicines
Mitsis A   +7 more
europepmc   +1 more source

Clinically actionable pharmacogenomic landscape of antidepressants and antipsychotics in Qatar: a population-based cohort study. [PDF]

open access: yesCamb Prism Precis Med
Velayutham D   +9 more
europepmc   +1 more source

Study on Second-line Helicobacter pylori Infection Eradication Therapy Based on CYP2C19 Genetic Polymorphism

open access: bronze, 2007
Daiki Tsuji   +7 more
openalex   +2 more sources

Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice. [PDF]

open access: yesFront Pharmacol
De Bellis M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy